ProfileGDS5678 / 1432054_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 8% 8% 8% 8% 8% 8% 7% 8% 8% 8% 8% 8% 8% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.199418
GSM967853U87-EV human glioblastoma xenograft - Control 22.178648
GSM967854U87-EV human glioblastoma xenograft - Control 32.181818
GSM967855U87-EV human glioblastoma xenograft - Control 42.1368
GSM967856U87-EV human glioblastoma xenograft - Control 52.128968
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.226018
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.185897
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.155138
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.152998
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.170858
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.165538
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.155118
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.16998
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.169738